» Articles » PMID: 31121127

Huntingtin Lowering Strategies for Disease Modification in Huntington's Disease

Overview
Journal Neuron
Publisher Cell Press
Specialty Neurology
Date 2019 May 24
PMID 31121127
Citations 21
Authors
Affiliations
Soon will be listed here.
Citing Articles

Latest advances on new promising molecular-based therapeutic approaches for Huntington's disease.

Cheng Y, Zhang S, Shang H J Transl Int Med. 2024; 12(2):134-147.

PMID: 38779119 PMC: 11107186. DOI: 10.2478/jtim-2023-0142.


High-throughput virtual screening of potential inhibitors of GPR52 using docking and biased sampling method for Huntington's disease therapy.

Gupta H, Sahi S Mol Divers. 2023; 28(5):3331-3347.

PMID: 38038795 DOI: 10.1007/s11030-023-10763-y.


Age- and region-dependent cortical excitability in the zQ175 Huntington disease mouse model.

Wang Y, Ramandi D, Sepers M, Mackay J, Raymond L Hum Mol Genet. 2023; 33(5):387-399.

PMID: 37947186 PMC: 10877458. DOI: 10.1093/hmg/ddad191.


Curcumin, inflammation, and neurological disorders: How are they linked?.

Garodia P, Hegde M, Kunnumakkara A, Aggarwal B Integr Med Res. 2023; 12(3):100968.

PMID: 37664456 PMC: 10469086. DOI: 10.1016/j.imr.2023.100968.


hESC-derived striatal progenitors grafted into a Huntington's disease rat model support long-term functional motor recovery by differentiating, self-organizing and connecting into the lesioned striatum.

Schellino R, Besusso D, Parolisi R, Gomez-Gonzalez G, Dallere S, Scaramuzza L Stem Cell Res Ther. 2023; 14(1):189.

PMID: 37507794 PMC: 10386300. DOI: 10.1186/s13287-023-03422-4.